These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 5107574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of facoor VIII and factor IX concentrates during surgery.
    George JN, Breckenridge RT.
    JAMA; 1970 Nov 30; 214(9):1673-6. PubMed ID: 5536529
    [No Abstract] [Full Text] [Related]

  • 3. Surgical procedures and hemophilia.
    McMaster WC.
    West J Med; 1975 Feb 30; 122(2):151. PubMed ID: 1114802
    [No Abstract] [Full Text] [Related]

  • 4. Surgery in hemophilic patients.
    Post M, Telfer MC.
    J Bone Joint Surg Am; 1975 Dec 30; 57(8):1136-45. PubMed ID: 1202004
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Problems posed by hemophilia].
    Biermé R.
    Anesth Analg (Paris); 1968 Dec 30; 25(2):125-31. PubMed ID: 5674775
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Management of hemophilia].
    Laurian Y.
    Rev Prat; 1989 Dec 21; 39(30):2669-73. PubMed ID: 2515580
    [Abstract] [Full Text] [Related]

  • 9. The use of continuous infusion of factor concentrates in the treatment of hemophilia.
    Bona RD, Weinstein RA, Weisman SJ, Bartolomeo A, Rickles FR.
    Am J Hematol; 1989 Sep 21; 32(1):8-13. PubMed ID: 2502914
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic properties and safety of recombinant factor VIII and factor IX.
    Zdziarska J, Chojnowski K, Klukowska A, Łetowska M, Mital A, Podolak-Dawidziak M, Windyga J, Zawilska K, Working Group on Hemostasis of the Polish Society of Hematologists and Transfusiologists.
    Pol Arch Med Wewn; 2009 Jun 21; 119(6):403-9. PubMed ID: 19694223
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
    Miranda ML, Lissen E, Vinuesa M, Jiménez JM, García de Pesquera F, Leal M.
    Med Clin (Barc); 1985 Apr 06; 84(13):516-9. PubMed ID: 3923278
    [No Abstract] [Full Text] [Related]

  • 13. Management of hemophiliac patients undergoing surgical procedures.
    Sampson JF, Hamstra R, Aldrete JA.
    Anesth Analg; 1979 Apr 06; 58(2):133-5. PubMed ID: 571236
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Factor products in the treatment of hemophilia.
    Miller KL.
    J Pediatr Health Care; 2004 Apr 06; 18(3):156-7. PubMed ID: 15129219
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hemophilia management in transfusion medicine.
    Poon MC, Card R.
    Transfus Apher Sci; 2012 Jun 06; 46(3):299-307. PubMed ID: 22503305
    [Abstract] [Full Text] [Related]

  • 18. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C, Patharathienskul D, Suvatte V.
    Southeast Asian J Trop Med Public Health; 1993 Jun 06; 24 Suppl 1():106-12. PubMed ID: 7886549
    [Abstract] [Full Text] [Related]

  • 19. The hemophilias--from royal genes to gene therapy.
    Mannucci PM, Tuddenham EG.
    N Engl J Med; 2001 Jun 07; 344(23):1773-9. PubMed ID: 11396445
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.